Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

University of Pittsburg Medical Center, Pittsburgh

Hospital of the University of Pennsylvania, Philadelphia

Walter Reed National Military Medical Center, Bethesda

Mercy Medical Center, Baltimore

Inova Fairfax Hospital, Falls Church

University of Virginia, Charlottesville

St. Mary's Hospital, Richmond

Virginia Commonwealth University Health System, Richmond

Mary Immaculate Hospital, Newport News

Indiana University School of Medicine, Indianapolis

Northwestern University, Chicago

Kansas City Research Institute, Kansas City

Methodist Dallas Medical Center, Dallas

Texas Clinical Research Institute, Arlington

CHI St. Luke's Health Baylor College of Medicine, Houston

American Research Corporation at Texas Liver Institute, San Antonio

Digestive Research Center, Live Oak

Brooke Army Medical Center Ft. Sam, Houston

University of Colorado Denver, Aurora

Intermountain Medical Center, Murray

University of California San Diego, San Diego

University of California San Francisco, San Francisco

Stanford University Medical Center, Palo Alto

Swedish Medical Center, Seattle

Beth Israel Deaconess Medical Center, Boston

Duke University Medical Center, Durham

University of Calgary, Calgary

Toronto Liver Centre, Toronto